NasdaqGS - Delayed Quote USD

AbCellera Biologics Inc. (ABCL)

4.0100 +0.1800 (+4.70%)
At close: 4:00:01 PM EDT
4.0500 +0.0400 (+1.00%)
After hours: 7:03:22 PM EDT
Trade ABCL on Coinbase
Chart Range Bar
Loading chart for ABCL
  • Previous Close 3.8300
  • Open 3.9200
  • Bid 3.9700 x 3100
  • Ask 4.0400 x 3100
  • Day's Range 3.8700 - 4.0500
  • 52 Week Range 1.9400 - 6.5150
  • Volume 4,764,504
  • Avg. Volume 3,527,350
  • Market Cap (intraday) 1.216B
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4900
  • Earnings Date May 11, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.43

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

www.abcellera.com

562

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview: ABCL

Trailing total returns as of 4/17/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ABCL
17.25%
S&P 500 (^GSPC)
4.10%

1-Year Return

ABCL
65.70%
S&P 500 (^GSPC)
34.89%

3-Year Return

ABCL
45.74%
S&P 500 (^GSPC)
71.66%

5-Year Return

ABCL
86.55%
S&P 500 (^GSPC)
70.26%

Earnings Trends: ABCL

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 44.85M
Earnings -8.95M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-40M
-20M
0
20M
40M
 

Analyst Insights: ABCL

View More

Analyst Price Targets

7.00
9.43 Average
4.0100 Current
12.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 4/10/2026
Analyst Jones Trading
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 11
 

Statistics: ABCL

View More

Valuation Measures

Annual
As of 4/16/2026
  • Market Cap

    1.16B

  • Enterprise Value

    770.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.23

  • Price/Book (mrq)

    1.20

  • Enterprise Value/Revenue

    10.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -194.88%

  • Return on Assets (ttm)

    -9.99%

  • Return on Equity (ttm)

    -14.47%

  • Revenue (ttm)

    75.13M

  • Net Income Avi to Common (ttm)

    -146.41M

  • Diluted EPS (ttm)

    -0.4900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    533.83M

  • Total Debt/Equity (mrq)

    14.81%

  • Levered Free Cash Flow (ttm)

    -176M

Compare To: ABCL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: ABCL

Fair Value

4.0100 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports: ABCL

View More
  • Daily – Vickers Top Buyers & Sellers for 03/02/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 12/01/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 11/28/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 03/12/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch